Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status

The large randomized placebo controlled trials of the Women’s Health Initiative have shown that the combination of estrogen and progestin medroxyprogesterone acetate (MPA) protects from colorectal cancer in postmenopausal women. No effect was observed in women treated with estrogen alone. This sugge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Meijer, Bartolomeus J., Wielenga, Mattheus C.B., Hoyer, Patricia B., Amos-Landgraf, James M., Hakvoort, Theodorus B.M., Muncan, Vanesa, Heijmans, Jarom, van den Brink, Gijs R.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078141/
https://ncbi.nlm.nih.gov/pubmed/30093969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados